Under the terms, the opioid maker agreed to pay $900m, and the family behind it agreed to pay up to $6.5bn.

Summary

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement over their role in the opioid crisis.

The deal, $1 billion larger than a previous 2024 proposal rejected by the Supreme Court, includes $6.5 billion from the Sacklers and $900 million from Purdue.

Funds will support opioid addiction treatment and prevention efforts.

The settlement, among the largest in U.S. history, still requires court approval.

Critics note the Sacklers’ $11 billion withdrawals before Purdue’s bankruptcy, and victims emphasize the ongoing human cost of the crisis.